Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Autolus Therapeutics (AUTL) Shares Outstanding: 2018-2024

Historic Shares Outstanding for Autolus Therapeutics (AUTL) over the last 5 years, with Dec 2024 value amounting to $34,425.

  • Autolus Therapeutics' Shares Outstanding changed negligibly% to $34,425 in Q4 2024 from the same period last year, while for Dec 2024 it was $34,425, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $34,425 for FY2024, which is negligibly% changed negligibly from last year.
  • Autolus Therapeutics' Shares Outstanding amounted to $34,425 in FY2024, which was down 0.00% from $34,425 recorded in FY2023.
  • In the past 5 years, Autolus Therapeutics' Shares Outstanding ranged from a high of $125.1 million in FY2021 and a low of $34,425 during FY2023.
  • Moreover, its 3-year median value for Shares Outstanding was $34,425 (2024), whereas its average is $57.7 billion.
  • As far as peak fluctuations go, Autolus Therapeutics' Shares Outstanding spiked by 90.38% in 2022, and later slumped by 100.00% in 2023.
  • Over the past 4 years, Autolus Therapeutics' Shares Outstanding (Yearly) stood at $90.9 billion in 2021, then skyrocketed by 90.38% to $173.1 billion in 2022, then tumbled by 100.00% to $34,425 in 2023, then remained steady at $34,425 in 2024.